[
  {
    "ts": null,
    "headline": "Why Moderna (MRNA) Shares Are Falling Today",
    "summary": "Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 4.8% in the afternoon session after competitors Pfizer and BioNTech announced positive topline results for their updated 2025-2026 COVID-19 vaccine formula. The data from Pfizer and BioNTech showed their vaccine produced a robust immune response, signaling continued strong competition in the COVID-19 vaccine market.",
    "url": "https://finnhub.io/api/news?id=5c4d0347fd13785e33f1c0dca96a95d59077c8fd8e8373697d1484d926da9792",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757359590,
      "headline": "Why Moderna (MRNA) Shares Are Falling Today",
      "id": 136689367,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 4.8% in the afternoon session after competitors Pfizer and BioNTech announced positive topline results for their updated 2025-2026 COVID-19 vaccine formula. The data from Pfizer and BioNTech showed their vaccine produced a robust immune response, signaling continued strong competition in the COVID-19 vaccine market.",
      "url": "https://finnhub.io/api/news?id=5c4d0347fd13785e33f1c0dca96a95d59077c8fd8e8373697d1484d926da9792"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Inc. (MRNA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)",
    "summary": "Discover Moderna's strategy for vaccine growth, cost control, and oncology innovation.",
    "url": "https://finnhub.io/api/news?id=9c1dc83dd6030fed48a69428174acdbe4d486088c8a2acc3fbdfb082011b6e53",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757337274,
      "headline": "Moderna, Inc. (MRNA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)",
      "id": 136670970,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Discover Moderna's strategy for vaccine growth, cost control, and oncology innovation.",
      "url": "https://finnhub.io/api/news?id=9c1dc83dd6030fed48a69428174acdbe4d486088c8a2acc3fbdfb082011b6e53"
    }
  }
]